Year
|
Student Name
|
Degree, University
|
Project Title
|
2000-2003
|
Mitchell Lai
|
PhD, Sydney University
|
Cholinergic and Serotonergic Neurochemistry of Alzheimer’s Disease
|
2003-2007
|
Shirley Tsang
|
PhD, NUS
|
Alterations of Cholinergic and Serotonergic Neurochemistry in Alzheimer’s Disease : Correlations With Cognitive And Behavioral Symptoms
|
2007-2011
|
Kaavya Narasimhalu
|
PhD, Karolinkska-NUS
|
Health Outcomes Associated With Cognitive Impairment
|
2007-2012
|
Katherine Kasiman
|
PhD, Karolinkska-NUS
|
The Role of Genetic and Molecular Markers in Ischemic Stroke
|
2008-2014
|
Jasinda Lee
|
PhD, NUS
|
Neurochemistry of G-Protein Coupled Receptors (GPCRs) in Dementia: Alterations and Correlations with Clinical Features
|
2008-2014
|
Nur-Exan Mohamed
|
PhD, NUS
|
Alterations In The Glutamatergic System And Their Associations With Clinical And Neuropathological Presentations Of Neurodegerative Diseases
|
2009-2014
|
Yuan Sheng
|
PhD, NUS
|
Histaminergic H3 And Cannabinoid Cb1 Receptors In Dementia
|
2009-2010
|
Catherine Goh
|
MSc, NUS
|
Investigating The Influence Of Age On Pharmacokinetic And Pharmacodynamic Characteristics Of Gold Standard Alzheimer’s Disease Drugs In The Lister-Hooded Rat
|
2009-2012
|
Yap Kwong Hsia
|
MPH, NUS
|
Measuring cognitive decline in persons with cognitive impairment.
|
2010-2012
|
Ma Lu
|
MSc, NUS
|
Inflammatory Biomarkers In Stroke And Dementia
|
2010-2014
|
Catherine Dong
|
PhD, UNSW
|
Cognitive outcome after stroke: Detection of vascular cognitive impairment, prognosis, neuropsychological patterns and the efficacy of revascularization
|
2011-2013
|
Saima Hilal
|
MPH, NUS
|
Quantitative Retinal Microvascular Parameters and Cerebral Microbleeds
|
2012-2012
|
Lauren Murray
|
MSc, University of Nottingham
|
Traditional Chinese Medication NeuroAid (MLC601) enhances α-secretase activity and attenuates β-amyloid production in vitro
|
2013-2015
|
Sabrina Zhang
|
MSc, NUS
|
Investigating the effects of amylin and high glucose in amyloid precursor peptide (APP) processing
|
2013-2016
|
Weng Jia Yu
|
MSc, NUS
|
Role of the Lysosomal system in Dementia
|
2013-2017
|
Xing Huayang
|
PhD, NUS
|
Increased Phosphorylation of Collapsin Response Mediator Protein and alpha-Synuclein: Novel Therapeutic Targets and Potential Molecular Mechanisms in Lewy Body Dementias
|
2013-2017
|
Zhu Yanan
|
PhD, NUS
|
Assessing the role of neuroinflammation, microRNA and efficacy of Traditional Chinese Herbal Medicines for Dementia
|
2014-2016
|
Saima Hilal
|
PhD, NUS
|
Retinal and Cerebral Neuroimaging Biomarkers for Cognitive Impairment
|
2016-2020
|
Bibek Gyanwali
|
PhD, NUS
|
Dementia Neuroimaging
|
2016-2020
|
Chai Yuek Ling
|
PhD, NUS
|
Vascular and Inflammatory Blood Biomarkers of Cognitive Impairment
|
2017-2022
|
Joyce Chong Ruifen
|
PhD, NUS
|
Lipid dysregulation in dementia
|
2018-2021
|
Poh Luting
|
PhD, NUS
|
The Role of Inflammasome in a Chronic Cerebral Hypoperfusion Mouse Model of Vascular Dementia
|
2018-2022
|
Sharmelee Selvaraji
|
PhD, NUS
|
Intermittent fasting: A potential modifier of DNA methylation landscape in a chronic cerebral hypoperfusion mouse model of Vascular Dementia
|
2018-2022
|
Vismitha Rajeev
|
PhD, NUS
|
Investigating Cerebral Vascular Integrity in a Chronic Cerebral Hypoperfusion Mouse Model of Vascular Dementia – From Pathophysiology to Treatment
|
2018-2022
|
Chua Xin Ying
|
PhD, NUS
|
The role of sphingolipids in the normal brain and in neurodegeneration
|
2019-2023
|
Wu Liuyun
|
PhD, NUS
|
Novel Oxidative Stress Related Blood biomarkers of Vascular Cognitive Impairment and Dementia
|
2020-2024
|
Kan Cheuk Ni
|
PhD, NUS
|
Biomarkers for the Neuropsychiatric Symptoms of Cognitive Impairment and Dementia
|
2022-2026
|
Liao Yingqi
|
PhD, NUS
|
Biomarkers for Mild Behavioural Impairment and Dementia
|
2023-2027
|
Sim Ming Ann
|
PhD, NUS
|
The role of novel blood-based biomarkers in ageing and neurocognitive decline
|
2023-2027
|
Choi Jiangbo
|
PhD, NUS
|
Vascular Risk Factors of Cognitive Impairment and Dementia
|